Taliglucerase alfa approved for Gaucher disease.
Kate
K
Traynor
D002986:Clinical Trials as Topic / Q000379:methods; D017277:Drug Approval; D056947:Enzyme Replacement Therapy / Q000379:methods; D005776:Gaucher Disease / Q000188:drug therapy* / Q000201:enzymology; D005962:Glucosylceramidase / Q000008:administration & dosage*; D006801:Humans; D007262:Infusions, Intravenous; D011994:Recombinant Proteins / Q000008:administration & dosage*; D014481:United States
D011994:Recombinant Proteins; D005962:Glucosylceramidase; C582473:taliglucerase alfa; C090568:imiglucerase